Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Patheon | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Patheon

Revenues from commercial manufacturing operations were $138.5 million (-3%) in the quarter.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon

2Q Revenues: $170.0 million (-3%)

2Q Loss: $11.2 million (earnings were $10.9 million in 2Q10)

YTD Revenues: $345.7 million (+5%)

YTD Loss: $10.7 million (loss of $0.2 million YTD10)

Comments: Revenues from commercial manufacturing operations were $138.5 million (-3%) in the quarter. Pharmaceutical Development Services (PDS) revenue was $31.5 million (-5%). Results in the quarter reflect contract cancellations and delays in the PDS business and an $8.8 million negative currency impact.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters